Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -6.5e-05 | 1 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -4e-05 | 1 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -6.3e-06 | 1 |